Clinical Trial Update: Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy [Phase 2]

View source ↗

Summary

Phase 2 trial assessing PROSTVAC-V/F as adjuvant therapy for prostate cancer in patients at high risk of relapse after radical prostatectomy was terminated, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PROSTVAC-V/F

Snippet

Sponsor: Medical University of South Carolina | Conditions: Prostatic Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2025-12-12